Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 2

Results: 20

Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03582-5

By:

Ma, Jietao;
Song, Jun;
Yi, Xiaofang;
Zhang, Shuling;
Sun, Li;
Huang, Letian;
Han, Chengbo

Publication type:

Article

Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03621-1

By:

Yanagisawa, Takafumi;
Mori, Keiichiro;
Matsukawa, Akihiro;
Kawada, Tatsushi;
Katayama, Satoshi;
Bekku, Kensuke;
Laukhtina, Ekaterina;
Rajwa, Pawel;
Quhal, Fahad;
Pradere, Benjamin;
Fukuokaya, Wataru;
Iwatani, Kosuke;
Murakami, Masaya;
Bensalah, Karim;
Grünwald, Viktor;
Schmidinger, Manuela;
Shariat, Shahrokh F.;
Kimura, Takahiro

Publication type:

Article

Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03584-3

By:

Zhu, Qin;
Cao, Yukun;
Yuan, Jiaqi;
Hu, Yu

Publication type:

Article

A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03625-x

By:

Luo, Yuejun;
Liu, Chengming;
Yao, Yuxin;
Tang, Xiaoya;
Yin, Enzhi;
Lu, Zhiliang;
Sun, Nan;
He, Jie

Publication type:

Article

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03618-w

By:

Zhang, Xiaomei;
Sun, Rui;
Zhang, Meng;
Zhao, Yifan;
Cao, Xinping;
Guo, Ruiting;
Zhang, Yi;
Liu, Xingzhong;
Lyu, Cuicui;
Zhao, Mingfeng

Publication type:

Article

Presence of Epstein–Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03617-x

By:

Mangiaterra, T.;
Alonso-Alonso, R.;
Rabinovich, A.;
De Dios Soler, M.;
Galluzzo, L.;
Soria, M.;
Colli, S.;
De Matteo, E.;
Rodriguez Pinilla, S. M.;
Chabay, P.

Publication type:

Article

The complex role of IL-10 in malignant ascites: a review.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03616-y

By:

Huang, Yue;
Zou, Kangni;
Jiang, Heng;
Li, Zhengyu

Publication type:

Article

Characterization of T cell receptor repertoire in penile cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03615-z

By:

Zhang, Junying;
Wang, Yapeng;
Huang, Yiqiang;
Tan, Xintao;
Xu, Jing;
Yan, Qian;
Tan, Jiao;
Zhang, Yao;
Zhang, Jun;
Ma, Qiang;
Zhu, Hailin;
Ye, Jin;
Zhu, Zhaojing;
Lan, Weihua

Publication type:

Article

Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03612-2

By:

Nikotina, Alina D.;
Vladimirova, Snezhana A.;
Kokoreva, Nadezhda E.;
Nevdakha, Valeria A.;
Lazarev, Vladimir F.;
Kuznetcova, Liubov S.;
Komarova, Elena Y.;
Suezov, Roman V.;
Efremov, Sergei;
Leonova, Elizaveta;
Kartsev, Viktor G.;
Aksenov, Nikolay D.;
Margulis, Boris A.;
Guzhova, Irina V.

Publication type:

Article

An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03610-4

By:

Yankilevich, Patricio;
Nazerai, Loulieta;
Willis, Shona Caroline;
Schmiegelow, Kjeld;
De Zio, Daniela;
Nielsen, Morten

Publication type:

Article

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03608-y

By:

Otsuka, Koji;
Isobe, Junya;
Asai, Yoshiyuki;
Nakano, Tomohisa;
Hattori, Kouya;
Ariyoshi, Tomotake;
Yamashita, Takeshi;
Motegi, Kentaro;
Saito, Akira;
Kohmoto, Masahiro;
Hosonuma, Masahiro;
Kuramasu, Atsuo;
Baba, Yuta;
Murayama, Masakazu;
Narikawa, Yoichiro;
Toyoda, Hitoshi;
Funayama, Eiji;
Tajima, Kohei;
Shida, Midori;
Hirasawa, Yuya

Publication type:

Article

Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03606-0

By:

Li, Xingchen;
Tian, Wenzhi;
Jiang, Zhongxing;
Song, Yongping;
Leng, Xiangyang;
Yu, Jifeng

Publication type:

Article

Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03605-1

By:

Sharma, Amit;
Ren, Xiubao;
Rosato, Antonio;
Sangiolo, Dario;
Wang, Zibing;
Tettamanti, Sarah;
Zhang, Yi;
Rettinger, Eva;
Fenix, Kevin Aaron;
Sommaggio, Roberta;
Cappuzzello, Elisa;
Schmidt-Wolf, Ingo G. H.

Publication type:

Article

Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03581-6

By:

Versluis, J. M.;
Hoefsmit, E. P.;
Shehwana, H.;
Dimitriadis, P.;
Sanders, J.;
Broeks, A.;
Blank, C. U.

Publication type:

Article

Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03578-1

By:

Gurrea-Rubio, Mikel;
Wu, Qi;
Amin, M. Asif;
Tsou, Pei-Suen;
Campbell, Phillip L.;
Amarista, Camila I.;
Ikari, Yuzo;
Brodie, William D.;
Mattichak, Megan N.;
Muraoka, Sei;
Randon, Peggy M.;
Lind, Matthew E.;
Ruth, Jeffrey H.;
Mao-Draayer, Yang;
Ding, Shengli;
Shen, Xiling;
Cooney, Laura A.;
Lin, Feng;
Fox, David A.

Publication type:

Article

CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03604-2

By:

Wang, Jianghua;
Li, Xiaoting;
Xiao, Guanxi;
Desai, Jayesh;
Frentzas, Sophia;
Wang, Zhongmin Maxwell;
Xia, Yu;
Li, Baiyong

Publication type:

Article

Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03598-x

By:

Lin, Xiuhua;
Tang, Shichuan;
Guo, Yutong;
Tang, Ruijing;
Li, Zhenli;
Pan, Xinting;
Chen, Geng;
Qiu, Liman;
Dong, Xiuqing;
Zhang, Ling;
Liu, Xiaolong;
Cai, Zhixiong;
Xie, Baosong

Publication type:

Article

Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03585-2

By:

Cheng, Debin;
Zhang, Zhao;
Liu, Dong;
Mi, Zhenzhou;
Tao, Weidong;
Fu, Jun;
Fan, Hongbin

Publication type:

Article

Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03588-z

By:

Mazzarello, Andrea N.;
Gugiatti, Elena;
Cossu, Vanessa;
Bertola, Nadia;
Bagnara, Davide;
Carta, Sonia;
Ravera, Silvia;
Salvetti, Chiara;
Ibatici, Adalberto;
Ghiotto, Fabio;
Colombo, Monica;
Cutrona, Giovanna;
Marini, Cecilia;
Sambuceti, Gianmario;
Fais, Franco;
Bruno, Silvia

Publication type:

Article

New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03602-4

By:

Jancewicz, Iga;
Śmiech, Magdalena;
Winiarska, Magdalena;
Zagozdzon, Radoslaw;
Wisniewski, Pawel

Publication type:

Article